Cytel and Citeline announce strategic partnership for enrollment planning
The partnership integrates Citeline's clinical trial data into Enforesys 4.0 to improve enrollment forecasting and feasibility.
Stay informed with the latest news and media coverage for the biggest companies in Biotechnology & Medical Research. We track all announcements, press releases, and industry mentions in real time, all in one place. Looking for another sector? Browse our industry database.
Last updated
The partnership integrates Citeline's clinical trial data into Enforesys 4.0 to improve enrollment forecasting and feasibility.
Net revenues rose 10.2% to $16.99 billion, with GAAP diluted EPS of $2.03 and adjusted diluted EPS of $3.65
PET imaging showed up to 34% reduction in SUV and 26% in SUVR in affected brain regions, consistent with prior patients.
A shareholder has become a substantial holder in Mesoblast as of July 31, 2026.
Unlock all announcements with a free trial
AbbVie lowered its full-year adjusted earnings outlook to account for its acquisition of Apogee Therapeutics, as the company logged higher profit and revenue in the...
Norovirus vaccine mRNA-1403 missed the Phase 3 interim efficacy bar in Moderna's Q2 2026 earnings disclosure Thursday, extending the world's most advanced norovirus vaccine trial...
AbbVie's Rinvoq has been approved by the European Commission (EC) to treat adults and adolescents 12 years and older with non-segmental vitiligo (NSV) who are...
July 31 (Reuters) - AbbVie trimmed its 2026 profit forecast on Friday to account for its planned Apogee Therapeutics acquisition, while topping second-quarter estimates on...
Unlock all articles with a free trial
Track Every Market Move
Follow your target companies and get daily news updates delivered straight to your inbox
Start for freeBrowse the top companies in Biotechnology & Medical Research and stay on top of their latest developments.